PubMed:27090298 / 815-1095 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T9","span":{"begin":0,"end":280},"obj":"Sentence"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-entities-OrganismTaxon-PD","denotations":[{"id":"T2","span":{"begin":225,"end":234},"obj":"OrganismTaxon"}],"attributes":[{"id":"A2","pred":"db_id","subj":"T2","obj":"NCBItxid:9347"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-entities","denotations":[{"id":"11234","span":{"begin":19,"end":23},"obj":"GeneOrGeneProduct"},{"id":"11235","span":{"begin":139,"end":146},"obj":"ChemicalEntity"},{"id":"11236","span":{"begin":151,"end":158},"obj":"GeneOrGeneProduct"},{"id":"11237","span":{"begin":170,"end":177},"obj":"ChemicalEntity"},{"id":"11238","span":{"begin":179,"end":184},"obj":"GeneOrGeneProduct"},{"id":"11239","span":{"begin":198,"end":207},"obj":"ChemicalEntity"}],"attributes":[{"id":"A21","pred":"db_id","subj":"11234","obj":"NCBIGene:2194"},{"id":"A22","pred":"db_id","subj":"11235","obj":"MESH:D005947"},{"id":"A23","pred":"db_id","subj":"11236","obj":"NCBIGene:3630"},{"id":"A24","pred":"db_id","subj":"11237","obj":"MESH:D005947"},{"id":"A25","pred":"db_id","subj":"11238","obj":"NCBIGene:3043"},{"id":"A26","pred":"db_id","subj":"11239","obj":"MESH:D002096"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T16","span":{"begin":19,"end":23},"obj":"GeneOrGeneProduct"},{"id":"T17","span":{"begin":74,"end":87},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":131,"end":146},"obj":"GeneOrGeneProduct"},{"id":"T19","span":{"begin":151,"end":158},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":160,"end":164},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":179,"end":184},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":198,"end":207},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":239,"end":251},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":253,"end":258},"obj":"GeneOrGeneProduct"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T15","span":{"begin":19,"end":23},"obj":"GeneOrGeneProduct"},{"id":"T16","span":{"begin":131,"end":146},"obj":"GeneOrGeneProduct"},{"id":"T17","span":{"begin":151,"end":158},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":160,"end":164},"obj":"GeneOrGeneProduct"},{"id":"T19","span":{"begin":198,"end":207},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":239,"end":251},"obj":"GeneOrGeneProduct"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T2","span":{"begin":239,"end":251},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D001724"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T9","span":{"begin":19,"end":23},"obj":"GeneOrGeneProduct"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T3","span":{"begin":239,"end":251},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"ID:","subj":"T3","obj":"D001724"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T10","span":{"begin":139,"end":146},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":170,"end":177},"obj":"ChemicalEntity"},{"id":"T16","span":{"begin":198,"end":207},"obj":"ChemicalEntity"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"D005947"},{"id":"A11","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A12","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D005947"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A15","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A16","pred":"ID:","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_80332"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T5","span":{"begin":225,"end":234},"obj":"OrganismTaxon"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T16","span":{"begin":198,"end":207},"obj":"ChemicalEntity"},{"id":"T13","span":{"begin":170,"end":177},"obj":"ChemicalEntity"},{"id":"T10","span":{"begin":139,"end":146},"obj":"ChemicalEntity"},{"id":"T79701","span":{"begin":19,"end":23},"obj":"GeneOrGeneProduct"},{"id":"T28411","span":{"begin":225,"end":234},"obj":"OrganismTaxon"}],"attributes":[{"id":"A16","pred":"ID:","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_80332"},{"id":"A15","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A14","pred":"ID:","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A13","pred":"ID:","subj":"T13","obj":"D005947"},{"id":"A12","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_17234"},{"id":"A11","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_4167"},{"id":"A10","pred":"ID:","subj":"T10","obj":"D005947"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T7","span":{"begin":59,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}

{"project":"Anatomy-MAT","denotations":[{"id":"T10","span":{"begin":59,"end":64},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"mat_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MAT_0000083"},{"id":"A11","pred":"mat_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MAT_0000315"}],"text":"Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p \u003c 0.05 to p \u003c 0.001)."}